Published in Hum Pathol on June 01, 1987
Analysis of prosthetic cardiac devices: a guide for the practising pathologist. J Clin Pathol (2005) 0.77
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest (2000) 4.79
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med (2001) 3.89
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
A mouse model of familial hypertrophic cardiomyopathy. Science (1996) 3.69
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation (1997) 3.38
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature (1996) 2.94
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest (2000) 2.56
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol (1999) 2.19
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U S A (1997) 2.15
An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation (2001) 2.09
Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg (1997) 2.05
Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A (1997) 2.02
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol (2001) 1.96
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol (1991) 1.82
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol (1996) 1.71
Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A (1998) 1.68
Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation (1991) 1.62
Power spectrum analysis of heart rate variability in human cardiac transplant recipients. Circulation (1989) 1.60
Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation (1991) 1.53
Surgical management of carcinoid heart disease. Ann Thorac Surg (1991) 1.50
Reduced nitrogen in ecology and the environment. Environ Pollut (2007) 1.49
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol (1992) 1.46
Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg (1998) 1.45
Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype. J Mol Cell Cardiol (2001) 1.43
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol (1983) 1.42
Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg (1993) 1.41
Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc (1989) 1.40
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol (2000) 1.40
Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Am J Cardiol (1999) 1.39
Targeted ablation of the murine alpha-tropomyosin gene. Circ Res (1997) 1.38
Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37
Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol (2001) 1.33
Toxicology and biocompatibility of bioglasses. J Biomed Mater Res (1981) 1.31
Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res (2001) 1.30
Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest (1999) 1.28
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.27
Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res (1987) 1.27
Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest (1985) 1.24
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol (1985) 1.22
Atherosclerotic aneurysms of aortocoronary vein grafts. Am J Cardiol (1988) 1.21
Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation (1995) 1.16
Antianginal effects of nitroglycerin patches. Am J Cardiol (1984) 1.16
Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 1.16
Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res (1999) 1.15
Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model. ASAIO Trans (1990) 1.13
Contribution of endothelial cells to calcium-dependent fluorescence transients in rabbit hearts loaded with indo 1. Circ Res (1990) 1.12
Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation (1983) 1.12
Cardiac effects of noncardiac neoplasms. Cardiol Clin (1984) 1.12
Effect of coronary reperfusion on myocardial hemorrhage and infarct healing. Am J Cardiol (1983) 1.11
AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model. ASAIO Trans (1989) 1.09
Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res (1998) 1.09
Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest (1988) 1.09
Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol (1986) 1.09
Dissecting aneurysm of the pulmonary trunk in mitral stenosis. Am J Cardiol (1986) 1.09
Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. Am J Clin Pathol (1983) 1.08
Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg (2000) 1.07
Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation (1983) 1.07
Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest (1992) 1.06
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest (1991) 1.06
The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol (1987) 1.06
Prediction of mechanical properties of human atherosclerotic tissue by high-frequency intravascular ultrasound imaging. An in vitro study. Arterioscler Thromb (1992) 1.06
Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol (1999) 1.03
Computational structural analysis based on intravascular ultrasound imaging before in vitro angioplasty: prediction of plaque fracture locations. J Am Coll Cardiol (1993) 1.02
Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis (1988) 1.02
Endothelial communication. State of the art lecture. Hypertension (1988) 1.02
Ultrafast three-dimensional contrast-enhanced magnetic resonance angiography and imaging in the diagnosis of partial anomalous pulmonary venous drainage. J Am Coll Cardiol (2001) 1.02
Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol (1983) 1.01
Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis (1997) 1.00
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. Ann Thorac Surg (1988) 0.99
Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol (1986) 0.99
Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol (1997) 0.99
Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res (1994) 0.98
Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res (1998) 0.98
Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol (1983) 0.96
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol (1994) 0.96
Amrinone in the treatment of chronic cardiac failure. J Am Coll Cardiol (1984) 0.95
Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res (1998) 0.95
Benign intracardiac thyroid mass causing right ventricular outflow tract obstruction. Am J Cardiol (1985) 0.95
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation (1993) 0.95
Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol (1995) 0.94
Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation (1994) 0.94
Effect of alpha naphthylthiourea on uptake of 5-hydroxytryptamine from the pulmonary circulation. Am Rev Respir Dis (1981) 0.93
Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg (1981) 0.93
Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science (1985) 0.93
Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. J Biomed Mater Res (1997) 0.93
Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg (2000) 0.93
Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol (1983) 0.92
Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol (1985) 0.92
Balloon dilatation of porcine bioprosthetic valves in the pulmonary position. Circulation (1987) 0.92